Here’s a summary of the provided text:
The article discusses a new treatment approach for metastatic prostate cancer, particularly for patients with “oligometastasis” (limited spread of cancer cells).Prostate cancer is a growing concern in Taiwan due to an aging population and increased screening.A recent study, the “EXTEND trial,” published in JAMA Oncology, investigated the effectiveness of adding radiation therapy to the treatment of metastatic prostate cancer. The results indicate that this combination can positively impact disease control and delay worsening.
Traditionally, systemic treatments like hormone therapy or chemotherapy where the primary approach for metastatic prostate cancer. However, recent research suggests that local treatments, like radiation therapy, can be beneficial, especially for patients with limited metastasis. The “EXTEND trial” specifically highlights that for patients with five or fewer metastases, “Metastasis-directed Therapy” (MDT) can improve condition control and delay progression.
Urologist Liu Ruiming and radiation oncologist Gao Yongshuo from Taoyuan Hospital participated in international discussions and wrote a comment letter to the journal, offering clinical opinions that were recognized. They emphasize that while a metastasis diagnosis can be distressing, medical advancements offer hope for stabilizing the condition and improving quality of life. They encourage patients and their families to actively engage with their medical team to develop the best treatment strategies.
The publication of their commentary in an international journal signifies the recognition of Taiwan’s clinical expertise and contributes to disseminating the latest research findings to frontline medical professionals, ultimately benefiting more patients. The article concludes by urging the public to increase awareness of early screening for prostate cancer to seize the optimal treatment opportunities.
